Eli Lilly
LLY
LLY
1,428 hedge funds and large institutions have $88.7B invested in Eli Lilly in 2018 Q3 according to their latest regulatory filings, with 147 funds opening new positions, 425 increasing their positions, 539 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.14% more ownership
Funds ownership: 76.89% → 77.04% (+0.14%)
20% less call options, than puts
Call options by funds: $703M | Put options by funds: $880M
21% less repeat investments, than reductions
Existing positions increased: 425 | Existing positions reduced: 539
Holders
1,428
Holding in Top 10
36
Calls
$703M
Puts
$880M
Top Buyers
| 1 | +$671M | |
| 2 | +$301M | |
| 3 | +$177M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$132M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$102M |
Top Sellers
| 1 | -$629M | |
| 2 | -$464M | |
| 3 | -$284M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$274M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$177M |